Suppr超能文献

A型产气荚膜梭菌肠毒素在纯化过程中的蛋白水解作用。

Proteolysis of Clostridium perfringens type A enterotoxin during purification.

作者信息

Park K B, Labbé R G

机构信息

Department of Food Science, University of Massachusetts, Amherst 01003.

出版信息

Infect Immun. 1990 Jun;58(6):1999-2001. doi: 10.1128/iai.58.6.1999-2001.1990.

Abstract

The small satellite bands of enterotoxin frequently seen in polyacrylamide gels following purification of Clostridium perfringens enterotoxin were found to be due to endogenous protease activity and were not present if phenylmethylsulfonyl fluoride (PMSF; 1 mM) and EDTA (10 mM) were used in the purification protocol. The use of PMSF was avoided by passing gel filtration-purified enterotoxin material through DEAE-Sephacel. This modified protocol resulted in an 11.4-fold purification of enterotoxin and a 26.8% yield. Contrary to previous reports (B. R. Dasgupta and M. W. Pariza, Infect. Immun. 38: 592-597, 1982), if PMSF and EDTA were included during purification, we were unable to detect the novel enterotoxin ET-1 produced by strain NCTC 10240. C. perfringens proteases cleaved homogeneous enterotoxin into two additional fragments, suggesting that ET-1 was a product of endogenous protease action during purification.

摘要

产气荚膜梭菌肠毒素纯化后在聚丙烯酰胺凝胶中经常见到的肠毒素小卫星带,被发现是由于内源性蛋白酶活性所致,如果在纯化方案中使用苯甲基磺酰氟(PMSF;1 mM)和乙二胺四乙酸(EDTA;10 mM),则不会出现这些小卫星带。通过使凝胶过滤纯化的肠毒素材料通过二乙氨基乙基纤维素(DEAE - Sephacel),避免了使用PMSF。这种改进的方案使肠毒素的纯化倍数达到11.4倍,产率为26.8%。与之前的报道(B. R. Dasgupta和M. W. Pariza,《感染与免疫》38: 592 - 597, 1982)相反,如果在纯化过程中加入PMSF和EDTA,我们无法检测到NCTC 10240菌株产生的新型肠毒素ET - 1。产气荚膜梭菌蛋白酶将纯肠毒素切割成另外两个片段,这表明ET - 1是纯化过程中内源性蛋白酶作用的产物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee1/258757/5d613d7d3db8/iai00054-0524-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验